Being overweight can also shrink lung size
Brain Research Bulletin , 161, 2938
May 2023 : The Acta Pharmaceutica Sinica B Journal published a letter on the potential adverse effects of GLP-1RAs, particularly on the small intestine
Animal studies show an increased risk of birth defects and pregnancy loss with semaglutide use
As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide works by enhancing insulin secretion in response to meals, suppressing glucagon release, slowing gastric emptying, and reducing appetite
Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study